{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Nm268AIDA","lastupdate":"2022-10-20T00:00:00.000Z","update_date":"2022-10-20T00:00:00.000Z","lastModified":"Aug 31, 2024","active":1,"confidence_score":90,"confidence_score_reason":"markets, not claimed","urlname":"cardiovalve","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by Venus Medtech on Mar, 2022","acquired":1,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$i6C7jfnextFw135p7zkAiPGmkjwJDwEXlPosQ6Vue8aJR9AP8jRwBO","name":"Cardiovalve","oneliner":"Cardiovascular Replacement Devices for Minimally Invasive Surgery","registrar":"514381060","website":"https://cardiovalve.com","careerspage":"","founded_month":2,"founded_year":2017,"formernames":["MITRALTECH"],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/33191238","instagram":""},"social":["https://www.linkedin.com/company/33191238"],"flattenedsociallinks":"https://www.linkedin.com/company/33191238","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"51-200","employees_exact":51,"patent":1,"raised":45483000,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Cardio valve","Valtech Cardio","Cardio.valve","Cardio-valve"],"about":"Cardiovalve is developing cardiovascular replacement devices for minimally invasive surgery.\r\n\r\nIts flagship system is designed to replace the mitral valve using a transfemoral system. Cardiovalve is designed from the bottom up for transfemoral/transseptal delivery with femoral venous access. This approach offers significant benefits including a short profile for minimal protrusion to the left ventricle, minimizing interference in the cardiac blood flow, and increased safety. \r\n\r\nThe company aims to bring to market a viable, clinically proven transfemoral alternative to open-heart surgery in which mitral regurgitation treatments are easier to perform for physicians, enabling patients to return to a healthy life after a quicker recovery.  \r\n\r\nCardiovalve received FDA approval for an Early Feasibility Study of its Transcatheter Tricuspid Valve Replacement System for a tricuspid regurgitation indication. The Cardiovalve System has also been granted Breakthrough Device Designation status by the FDA. Cardiovalve is a spin-off of Valtech Cardio, which was acquired by Edwards Lifesciences in 2017.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"6778c5da-ec26-4470-92fb-6116f401f4ec","city":"Or Yehuda","type":null,"address":"Yehadut Canada St 1, Or Yehuda, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"YvUFLnPXfnCgRWMOjggVoi6AhcfmA2RCnHNikNrHLJipeR3erl14kh","date":"Jan 27, 2022","link":"https://www.mpo-mag.com/contents/view_breaking-news/2022-01-27/venus-medtech-completes-equity-interest-deal-with-cardiovalve/","source":"www.mpo-mag.com","visible":1,"analysis":{"tags":"acquisition","company":"Venus Medtech","layoffs":null,"summary":"Chinese company Venus Medtech has completed its acquisition of Israeli transcatheter mitral and tricuspid valve treatment firm Cardiovalve. The acquisition allows Venus Medtech to become a market leader in the Chinese mitral and tricuspid regurgitation treatment markets. Cardiovalves transfemoral approach and innovative valve design have earned FDA early feasibility study approval for both indications. The market value for mitral and tricuspid regurgitation interventional therapy is expected to reach $5 billion by 2028. The acquisition is seen as a significant step in Venus Medtechs international development strategy.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["transcatheter mitral and tricuspid valve treatment","equity interest","market value","FDA approval","cross-border acquisition"],"date_of_event":"2022-01-26","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":null,"structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"w0MDBCPr34l2VUpnQl69K63apGpd1QdlbR7RjLyOzjTPBzL1EslY5A","news_summary":"Venus Medtech Completes Equity Interest Deal with Cardiovalve","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"91ae1121-7e3d-4af5-892b-902d90bdeea6","date":"Dec 8, 2021","link":"https://en.globes.co.il/en/article-chinas-venus-medtech-buys-israeli-co-cardiovalve-1001393658","source":"en.globes.co.il","visible":1,"analysis":{"tags":"acquisition","company":"Cardiovalve","layoffs":null,"summary":"Israeli heart valve treatment company Cardiovalve has been acquired by Chinese company Venus Medtech for $150 million upfront and an additional $150 million dependent on reaching regulatory milestones. Venus Medtech has also committed to investing another $100 million in Cardiovalve. Cardiovalve was founded by CEO Amir Gross, who previously founded Valtech Cardio. Valtech Cardio was acquired by Edwards Lifesciences in 2017 for $340 million upfront and a potential total consideration of $1 billion. The investors of Valtech Cardio have received an estimated $500-600 million. Venus Medtech is a major player in the Chinese heart medical devices market and has a market cap of $1.6 billion. The acquisition is expected to contribute to the growth of Cardiovalve in the global market.","partners":null,"customers":null,"investors":"Venus Medtech","confidence":9,"key_topics":["sale","investment","heart valve treatment","Chinese market","medical devices"],"date_of_event":"December 8, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":"$150 million upfront, $150 million dependent on milestones","structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Tg9ut4ebFWb7ij6UPTlAGJmm7fq9fvtMpvtIK2suBGOkpD8VukpRFg","news_summary":"China's Venus Medtech buys Israeli co Cardiovalve","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"357468bf-3389-45b1-bd05-c4ae58f59b12","date":"Aug 25, 2020","link":"https://en.globes.co.il/en/article-cardiovalve-simplifies-heart-valve-replacement-1001340518","source":"en.globes.co.il","visible":1,"analysis":{"tags":"medical technology","company":"Cardiovalve","layoffs":null,"summary":"Israeli company Cardiovalve, a spin-off of Valtech Cardio, is developing a device for minimally-invasive valve replacement. The companys product offers several benefits, including different sizes suitable for 95% of the population and a delivery system that saves on costs. Edwards Lifesciences, which acquired Valtech in 2017, did not acquire Cardiovalves next-generation product but has invested in the company. Cardiovalve has received about $40 million in investments, and the market for minimally invasive mitral valve replacement is estimated at $3-3.5 billion. The company aims to begin trials for marketing approval in Europe later this year and enter the market in about four years. Cardiovalve has also developed a product for the tricuspid valve.","partners":null,"customers":null,"investors":"Peregrine Ventures, GlenRock, Pertec Management, OXO Capital Valve Ventures, NGN Capital, Edwards","confidence":9,"key_topics":["minimally invasive valve replacement","mitral valve","product development","investment","market entry"],"date_of_event":"August 25, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$40 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"LqaDS7HEqKvBEarXktEIoX1JcAxuzW2ZlDbBcHllIQJtHkz1TTMex9","news_summary":"Cardiovalve simplifies heart valve replacement","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"61fd9a59-d1d5-4b51-ad2f-b6535b33775b","date":"Feb 20, 2020","link":"https://www.businesswire.com/news/home/20200220005629/en/Cardiovalve-Receives-%E2%80%98Breakthrough-Device-Designation%E2%80%99-Transcatheter-Tricuspid","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"dZzJbLdTDTW3EOM5wB7aOnxkqJlSmeSgpGqMRYB9upgzAow6JfDX1s","news_summary":"Cardiovalve Receives 'Breakthrough Device Designation' for Its Transcatheter Tricuspid Valve Replacement System","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":4,"techcommunityinvolvement":null,"mediagallery":[{"id":"cf44c0ec-e106-4460-b7b2-053c8748c178","timestamp":"2020-08-25 12:36:35.000000","resources_type":1,"resources_title":"","resources_file_name":"$ruDRiA3JveUapEAf0dcqJRCTuEkLzZiJyt2bZ06kqJJLrulqTEk0df","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$ruDRiA3JveUapEAf0dcqJRCTuEkLzZiJyt2bZ06kqJJLrulqTEk0df","url":"https://storage.googleapis.com/clean-finder-353810/$ruDRiA3JveUapEAf0dcqJRCTuEkLzZiJyt2bZ06kqJJLrulqTEk0df"}],"tags":["doctors","catheters","surgery","valves","hospitals","medical-devices","cardiology","heart-diseases","minimally-invasive"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"R&D","products":[],"geomarkets":["Europe"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":6,"lastfunding":"$40M","totalrounds":2,"fundingstage":"Acquired","totalfunding":"$45.48M","publicinvestors":6,"lastpublicfunding":40000000,"totalpublicrounds":2,"totalpublicfunding":45483000},"team":[{"name":"Amir  Gross","email":"amir@cardiovalve.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OmAiqcIDA","bounced":false,"claimed":0,"founder":1,"urlname":"amir-gross","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgmfCflAsM","position":"CEO","last_name":"Gross","claimtoken":"flwnvH9UyxOBC0w89BOhMbFy8wvcgvqdszYv1ycnqUZwNGA1Xy7Ccw","first_name":"Amir ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/amir-gross-7641b171/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-20 21:13:36.000000","initials":"AG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Yifat Rozenberg","email":"yifat@cardiovalve.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4Nm3-ZAJDA","bounced":false,"claimed":0,"founder":0,"urlname":"yifat-rozenberg","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg2ZyOiAsM","position":"CFO","last_name":"Rozenberg","claimtoken":"ZHIIUUVKY2yl00gbXSshbL9PRNfH5tM8MKW0ZGeyn4oz5bIFPFAPsp","first_name":"Yifat","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yifat-rozenberg-18937350/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-20 21:13:35.000000","initials":"YR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":" Meni  Yamberger","email":"meni@cardiovalve.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OmU15kKDA","bounced":false,"claimed":0,"founder":0,"urlname":"meni-yamberger","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDguZqThQoM","position":"VP","last_name":"Yamberger","claimtoken":"tMQlRI6takCt4HMYjpXqBdFH214NXscSMJyRcruChUfbJPlxe7UGjN","first_name":" Meni ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/meniyamberger/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-20 21:13:40.000000","initials":" Y","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqyo8cLDA","fullname":"Yotam Maman"},"biverifydate":"2020-08-26T00:00:00.000Z","crunchbaseid":"cardiovalve","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Yanina Wainscheinker","creator_email":"yanina.wain@gmail.com","createdate":"2020-08-25T00:00:00.000Z","biverification":"Yotam Maman","sectorverification":null,"affiliatedOrganizations":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6OibwKDA","name":"Valtech Cardio","type":"Startup","hidden":false,"fullurl":"/company_page/valtech-cardio","logokey":"$o31TmyCXhPdc5uZyFZhSmU4MGWaGBqNrkXxuGyAA6SSjPoxZxsb6GQ","logourl":"https://storage.googleapis.com/clean-finder-353810/$o31TmyCXhPdc5uZyFZhSmU4MGWaGBqNrkXxuGyAA6SSjPoxZxsb6GQ","onClick":"","visibilityClassName":"","visibilityTooltip":""}],"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDYtNTTCQw","date":"Mar 2022","amount":"$150M","source":"https://en.globes.co.il/en/article-chinas-venus-medtech-buys-israeli-co-cardiovalve-1001393658","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Venus Medtech","acquiredcompany_mna_id":"EZRZxbP5esmtlYjaKydqAhd19yZnCca1zKZzWdUg1PYZKANoNaucSl","acquiredcompany_mna_type":"Multinational","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/mnc_page/venus-medtech","acquiredcompany_mna_logokey":"$c9T4Ak6qYW5polwO3U8ZsaQ30n1GEEdlw7r8rHnCJ0o6o9LCHYQKQu.png","acquiredcompany_mna_urlname":"/mnc_page/venus-medtech","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$c9T4Ak6qYW5polwO3U8ZsaQ30n1GEEdlw7r8rHnCJ0o6o9LCHYQKQu.png","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":150000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCp_uP0CQw","date":"Aug 2020","amount":"$40M","source":"https://en.globes.co.il/en/article-cardiovalve-simplifies-heart-valve-replacement-1001340518, Amit from Peregrine sent a file","eventtype":"FundingRoundEvent","investment":[{"name":"Edwards Lifesciences","type":"Multinational","amount":0,"hidden":false,"country":"United States","fullurl":"/mnc_page/edwards-lifesciences","logokey":"$QAq1UVHUyvZfQHoOpTRfdPKCSiO5kPNvrNHg2JkzjCV3olUzNlMzSW","tagline":"Medical Devices and Equipment and Supplies","urlname":"/mnc_page/edwards-lifesciences","isisraeli":null,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwKqO6Y4KDA","fundingtype":"Multinational","leadpartner":null,"investmentid":"03dYt68ZHYd02rLlN5q2i3GBFZaJKuXb09GYTGWCPRaoXOjykLL2o1","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$QAq1UVHUyvZfQHoOpTRfdPKCSiO5kPNvrNHg2JkzjCV3olUzNlMzSW","leadcaption":"","followupcaption":""},{"name":"OXO Ventures","type":"Accelerator","amount":0,"hidden":true,"country":"Hungary","fullurl":"/program_page/oxo-ventures","logokey":"$CgObtnRKkfPBcxDfKb98a3g10cwHtAEyjZYPmMwaguSasAuf19QMSI","tagline":"","urlname":"/program_page/oxo-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEtfqYCgw","fundingtype":"General","leadpartner":null,"investmentid":"5B1eoMibWjV8rpcvfo4pov1ysuPGPJWeaw75HTeBIAVcY0VNEBkPe4","fundingsubtype":"General","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CgObtnRKkfPBcxDfKb98a3g10cwHtAEyjZYPmMwaguSasAuf19QMSI","leadcaption":"","followupcaption":""},{"name":"NGN Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ngn-capital","logokey":"$CkvsPhpajEMrG7rhuoruC7IarcrQHdlt0gbZv9KuY1RzfT7tLywca7","tagline":"","urlname":"/investor_page/ngn-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEvJqWCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"CF5DWjoLuC0DE7NUpyGCCVnlI2yic1zt3BKvEDo6LHwT9sRiK6MLU3","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CkvsPhpajEMrG7rhuoruC7IarcrQHdlt0gbZv9KuY1RzfT7tLywca7","leadcaption":"","followupcaption":""},{"name":"Peregrine Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"MGndUKMXztPeOrz8fOM9jFQ0B3WJpPWaNGqF2BW5KacPFszINtSztr","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":"Follow on "},{"name":"Amir Gross","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/amir-gross","logokey":null,"tagline":"","urlname":"/investor_page/amir-gross","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODkguiGCQw","fundingtype":"Angel","leadpartner":null,"investmentid":"PqW56idLAIeUPPD1ttFhKqSKZPIaafe73M4ivI8SwlPQ2n9cQv2bzc","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"GlenRock Group","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/glenrock-group","logokey":"$SLSOZcnim1CwahiL0ac3MVPpEEquU68P7FNfGOO3vXKYlear1Py6TN","tagline":null,"urlname":"/investor_page/glenrock-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMmxpp8JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"rpAU2hatsLRZGuC6mb1jPT2C7w5YfrPfNGXrI0o3JgQMePSPYWF8rV","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SLSOZcnim1CwahiL0ac3MVPpEEquU68P7FNfGOO3vXKYlear1Py6TN","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":40000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"XQVC4msKHCkUnuk2oFeMRBL2f13GLrN9diUaXYU9xOJlMv72sIoKHm","date":"Nov 2016","amount":"$5.48M","source":"Amit from Peregrine sent a file","eventtype":"FundingRoundEvent","investment":[{"name":"Peregrine Ventures","type":"Investor","amount":5483000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"rVedQLNMO0Hz4DxMS0XBc7X7SK00noIG58Yh9NYqurJLDQSPChiWS1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5483000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"2/2017","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Cardiovalve","logourl":"https://storage.googleapis.com/clean-finder-353810/$i6C7jfnextFw135p7zkAiPGmkjwJDwEXlPosQ6Vue8aJR9AP8jRwBO","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$i6C7jfnextFw135p7zkAiPGmkjwJDwEXlPosQ6Vue8aJR9AP8jRwBO","seoabout":"Cardiovalve is developing cardiovascular replacement devices for minimally invasive surgery.\r\n\r\nIts flagship system is designed to replace the mitral valve...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationDelimited":["IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"},{"title":"Patients","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Materials & Substances"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Patients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDYtNTTCQw","date":"Mar 2022","amount":"$150M","source":"https://en.globes.co.il/en/article-chinas-venus-medtech-buys-israeli-co-cardiovalve-1001393658","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Venus Medtech","acquiredcompany_mna_id":"EZRZxbP5esmtlYjaKydqAhd19yZnCca1zKZzWdUg1PYZKANoNaucSl","acquiredcompany_mna_type":"Multinational","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/mnc_page/venus-medtech","acquiredcompany_mna_logokey":"$c9T4Ak6qYW5polwO3U8ZsaQ30n1GEEdlw7r8rHnCJ0o6o9LCHYQKQu.png","acquiredcompany_mna_urlname":"/mnc_page/venus-medtech","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$c9T4Ak6qYW5polwO3U8ZsaQ30n1GEEdlw7r8rHnCJ0o6o9LCHYQKQu.png","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":150000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCp_uP0CQw","date":"Aug 2020","amount":"$40M","source":"https://en.globes.co.il/en/article-cardiovalve-simplifies-heart-valve-replacement-1001340518, Amit from Peregrine sent a file","eventtype":"FundingRoundEvent","investment":[{"name":"Edwards Lifesciences","type":"Multinational","amount":0,"hidden":false,"country":"United States","fullurl":"/mnc_page/edwards-lifesciences","logokey":"$QAq1UVHUyvZfQHoOpTRfdPKCSiO5kPNvrNHg2JkzjCV3olUzNlMzSW","tagline":"Medical Devices and Equipment and Supplies","urlname":"/mnc_page/edwards-lifesciences","isisraeli":null,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwKqO6Y4KDA","fundingtype":"Multinational","leadpartner":null,"investmentid":"03dYt68ZHYd02rLlN5q2i3GBFZaJKuXb09GYTGWCPRaoXOjykLL2o1","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$QAq1UVHUyvZfQHoOpTRfdPKCSiO5kPNvrNHg2JkzjCV3olUzNlMzSW","leadcaption":"","followupcaption":""},{"name":"OXO Ventures","type":"Accelerator","amount":0,"hidden":true,"country":"Hungary","fullurl":"/program_page/oxo-ventures","logokey":"$CgObtnRKkfPBcxDfKb98a3g10cwHtAEyjZYPmMwaguSasAuf19QMSI","tagline":"","urlname":"/program_page/oxo-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEtfqYCgw","fundingtype":"General","leadpartner":null,"investmentid":"5B1eoMibWjV8rpcvfo4pov1ysuPGPJWeaw75HTeBIAVcY0VNEBkPe4","fundingsubtype":"General","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CgObtnRKkfPBcxDfKb98a3g10cwHtAEyjZYPmMwaguSasAuf19QMSI","leadcaption":"","followupcaption":""},{"name":"NGN Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ngn-capital","logokey":"$CkvsPhpajEMrG7rhuoruC7IarcrQHdlt0gbZv9KuY1RzfT7tLywca7","tagline":"","urlname":"/investor_page/ngn-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEvJqWCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"CF5DWjoLuC0DE7NUpyGCCVnlI2yic1zt3BKvEDo6LHwT9sRiK6MLU3","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CkvsPhpajEMrG7rhuoruC7IarcrQHdlt0gbZv9KuY1RzfT7tLywca7","leadcaption":"","followupcaption":""},{"name":"Peregrine Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"MGndUKMXztPeOrz8fOM9jFQ0B3WJpPWaNGqF2BW5KacPFszINtSztr","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":"Follow on "},{"name":"Amir Gross","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/amir-gross","logokey":null,"tagline":"","urlname":"/investor_page/amir-gross","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODkguiGCQw","fundingtype":"Angel","leadpartner":null,"investmentid":"PqW56idLAIeUPPD1ttFhKqSKZPIaafe73M4ivI8SwlPQ2n9cQv2bzc","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"GlenRock Group","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/glenrock-group","logokey":"$SLSOZcnim1CwahiL0ac3MVPpEEquU68P7FNfGOO3vXKYlear1Py6TN","tagline":null,"urlname":"/investor_page/glenrock-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMmxpp8JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"rpAU2hatsLRZGuC6mb1jPT2C7w5YfrPfNGXrI0o3JgQMePSPYWF8rV","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SLSOZcnim1CwahiL0ac3MVPpEEquU68P7FNfGOO3vXKYlear1Py6TN","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":40000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"XQVC4msKHCkUnuk2oFeMRBL2f13GLrN9diUaXYU9xOJlMv72sIoKHm","date":"Nov 2016","amount":"$5.48M","source":"Amit from Peregrine sent a file","eventtype":"FundingRoundEvent","investment":[{"name":"Peregrine Ventures","type":"Investor","amount":5483000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"rVedQLNMO0Hz4DxMS0XBc7X7SK00noIG58Yh9NYqurJLDQSPChiWS1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5483000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}